Diagnostic Test Needs for Evaluating Antituberculosis Vaccines
Open Access
- 1 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (Supplement) , S276-S278
- https://doi.org/10.1086/313873
Abstract
To aid in the evaluation of preexposure and postinfection vaccines to prevent tuberculosis, diagnostic tests are needed that can clearly distinguish immunologic protection from vaccine failure in a timely manner. The currently available tests to detect infected persons (tuberculin skin-test) and confirm active disease (conventional culture methods) have limitations in speci-ficity, sensitivity, or timeliness. Research to identify (1) surrogate markers of infection, disease, or protection and (2) stage-specific antigens or immune responses holds some promise for the development of new tests that can distinguish the various outcomes of an infection or a vaccination.Keywords
This publication has 6 references indexed in Scilit:
- Molecular Approaches to the Diagnosis of TuberculosisPublished by American Society for Microbiology ,2014
- The Tuberculin Skin TestClinical Infectious Diseases, 1993
- Diagnostic Standards and Classification of TuberculosisAmerican Review of Respiratory Disease, 1990
- DIAGNOSIS OF TUBERCULOUS MENINGITIS BY DETECTION OF TUBERCULOSTEARIC ACID IN CEREBROSPINAL FLUIDThe Lancet, 1987
- Tuberculin Test in Retrospect and ProspectArchives of environmental health, 1967
- Weitere Mittheilung über das TuberkulinDeutsche Medizinische Wochenschrift (1946), 1891